Halt Medical, Inc. Announces Initial Commercial Results; Expanded Launch of Acessa™ System
4/1/2013 9:40:02 AM
More...
|
Halt Medical, Inc. Announces the First Commercial Use of the Acessa™ System
3/12/2013 10:02:30 AM
More...
|
Halt Medical, Inc. Introduces Team to Commercialize Acessa™ System for the Treatment of Uterine Fibroids
1/9/2013 9:12:41 AM
More...
|
American Capital and Its Affiliates Invest $10.7 Million in Portfolio Company Halt Medical, Inc.
1/8/2013 7:32:09 AM
More...
|
Halt Medical, Inc. Nabs $15 Million Financing for Commercialization of Acessa Uterine Fibroid Treatment System
1/2/2013 7:01:23 AM
More...
|
Halt Medical, Inc. Lands FDA Nod for Game-Changing Uterine Fibroid Treatment
11/7/2012 6:20:32 AM
More...
|
Halt Medical, Inc. Closes on First $20 Million of a $50 Million Financing
2/14/2012 6:39:47 AM
More...
|
Halt Medical, Inc. Presents Strong Results of International Fibroid Studies at National Institutes of Health (NIH) Global Congress
12/20/2010 9:16:20 AM
More...
|
Halt Medical, Inc. Receives Canadian License for Fibroid Treatment Device
10/19/2010 7:19:08 AM
More...
|